Public-registry site landscape for NCT03833388, a Dry Eye Syndrome study sponsored by Topivert Pharma Ltd. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03833388 (registry record) |
| Sponsor | Topivert Pharma Ltd |
| Condition(s) | Dry Eye Syndrome |
| Phase | PHASE2 / PHASE3 |
| Listed sites | 4 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT03833388 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →